Navigation Links
TRiUS Data Suggests That Testim® Significantly Improved Sexual Function in Hypogonadal Men
Date:11/3/2011

 Once Testim is absorbed through the skin, it enters the bloodstream and helps return testosterone to normal levels.  The efficacy of Testim has been demonstrated in 16 clinical studies involving approximately 1,800 patients, including the largest placebo-controlled study ever conducted to evaluate the benefits and risks of testosterone replacement therapy.  For information regarding the safety and use of Testim, please see the prescribing information at www.testim.com.  

About Auxilium

Auxilium Pharmaceuticals, Inc. is a specialty biopharmaceutical company with a focus on developing and marketing products to predominantly specialist audiences, such as urologists, endocrinologists, certain targeted primary care physicians, hand surgeons, subsets of orthopedic, general, and plastic surgeons who focus on the hand, and rheumatologists. Auxilium markets XIAFLEX® (collagenase clostridium histolyticum) for the treatment of adult Dupuytren's contracture patients with a palpable cord and Testim® 1%, a testosterone gel, for the topical treatment of hypogonadism in the U.S. Pfizer has marketing rights for XIAPEX® (the EU tradename for collagenase clostridium histolyticum) in Europe and Asahi Kasei Pharma Corporation has development and commercial rights for XIAFLEX in Japan. Ferring International Center S.A. markets Testim in the EU and Paladin Labs Inc. markets Testim in Canada. Auxilium has three projects in clinical development. XIAFLEX is in phase III of development for the treatment of Peyronie's disease, in phase IIa of development for the treatment of Frozen Shoulder syndrome (Adhesive Capsulitis) and is in phase Ib of development for the treatment of cellulite (edematous fibrosclerotic panniculopathy). Auxilium also has rights to pursue additional indications for XIAFLEX. For additional information, visit http://www.auxilium.com.


'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Trius Announces Issuance of Key U.S. Patent for Torezolid Phosphate
2. Trius Reports New Findings on Mechanisms of Antibiotic Resistance in MRSA
3. Trius to Present at the Stifel Nicolaus Healthcare Conference
4. Trius Therapeutics Obtains Special Protocol Assessment With FDA for Phase 3 Study of Torezolid Phosphate
5. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
6. Trius Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
7. Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
8. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
9. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
10. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
11. Trius Doses First Patient in Antibacterial Phase 2 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... The western European automated endoscope reprocessor ... a replacement market with fewer new installations due ... partnerships are redefining competitive landscape in western ... details about revenue forecasts, unit shipments, market share ... country. The changing landscape makes it important to ...
(Date:9/22/2014)... -- Research and Markets  has announced the addition ... report to their offering. This newly ... up-to-date publication available covering the neurotechnology industry. The report ... and growth rates in four key segments of the ... forecasts the number of systems to be sold, worldwide ...
(Date:9/22/2014)... , Sept. 22, 2014 Children,s National ... Monday, Sept. 29 at 5 p.m. EDT for ... competition, in response to continued strong interest from ... each will be awarded to the winning presentations ... Innovation Symposium hosted by Children,s National in October. ...
Breaking Medicine Technology:Automated Endoscope Reprocessor Market Trends in Western Europe 2Automated Endoscope Reprocessor Market Trends in Western Europe 3The Market for Neurotechnology: 2014-2018 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 2Calling all medical innovators: Submit your pediatric medical device pitch for Children's National competition by Sept. 29 3
... , Increased vaccination ... gaps remain, others must join effort , DAVOS, Switzerland ... announced today that their foundation will commit $10 billion ... deliver vaccines for the world,s poorest countries. , (Photo: ...
... , , REDWOOD CITY, Calif. ... today announced financial results for its fiscal second quarter and six months ... call at 4:30 p.m. Eastern Time to discuss the financial ... quarter, as we continued to transition the sales model for our cardiac ...
Cached Medicine Technology:Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 2Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 3Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 4Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 5Bill and Melinda Gates Pledge $10 Billion in Call for Decade of Vaccines 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 2Cardica Announces Fiscal 2010 Second Quarter Financial Results 3Cardica Announces Fiscal 2010 Second Quarter Financial Results 4Cardica Announces Fiscal 2010 Second Quarter Financial Results 5Cardica Announces Fiscal 2010 Second Quarter Financial Results 6Cardica Announces Fiscal 2010 Second Quarter Financial Results 7Cardica Announces Fiscal 2010 Second Quarter Financial Results 8Cardica Announces Fiscal 2010 Second Quarter Financial Results 9
(Date:9/23/2014)... Sandpoint, Idaho (PRWEB) September 23, 2014 ... GunSafes.com is now offering SecureIt Tactical products ... prices. SecureIt Tactical, Inc. holds a good name in ... The company stores only the finest products and now ... tactical gun safes such as the MilSpec Tactical Safe ...
(Date:9/22/2014)... Vida Cannabis Corp . is ... Agreement with Florida-based AltMed LLC . , ... and technical expertise. They’ll also pool business development ... markets. , "We’re deeply impressed with the level ... Cannabis team as they work toward building the most ...
(Date:9/22/2014)... Detroit MI (PRWEB) September 23, 2014 ... 3 organization dedicated to serving patients, caregivers and families ... of Philip M. Fortier of Detroit, MI to its ... disease of the brain and spinal cord, and is ... addition to resembling Parkinson’s disease (MSA Type P), MSA ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Airbus Helicopters ... industry Monday for their efforts to improve safety and ... Award and the Program of the Year award, both ... Air Medical Transport Conference Annual Community Awards. , ... with the Jim Charlson Aviation Safety Award, given annually ...
(Date:9/22/2014)... United States District Judge Joseph ... mesh lawsuits ( http://www.meshinjurylawfirm.com/lawsuits/ ) filed against defendant ... pretrial matters, issued an order in the multidistrict ... Products Liability Litigation (United States District Court for ... 2:12-md-02326)—requiring that four member cases be ready for ...
Breaking Medicine News(10 mins):Health News:GunSafes.com Now Offers Secure Tactical Range of Gun Safes 2Health News:Vida Cannabis Allies with Florida Medical Cannabis Leader AltMed to Build Best-in-Class Expertise 2Health News:Philip Fortier appointed to Multiple System Atrophy Coalition Board of Directors 2Health News:Philip Fortier appointed to Multiple System Atrophy Coalition Board of Directors 3Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 2Health News:Airbus Helicopters Inc. Honors Leaders in Air Medical Industry 3Health News:Federal Court Sets Trial Date for Boston Scientific Vaginal Mesh Cases in Florida, the Rottenstein Law Group LLP Reports 2
... U.S. Environmental,Protection Agency has given $97,204 to ... providers and women of child-bearing age on,environmental health ... grants nationwide. In Ohio, the grant will be ... woman,s potential exposure to environmental,risks., The EPA ...
... N.J., Feb. 4 NPS Pharmaceuticals,Inc. (Nasdaq: NPSP ... and chief operating officer, is scheduled to present at ... York on Monday, February,11, 2008 at 1:15 p.m. ET. ... a replay available approximately three hours after the,presentation has ...
... MONDAY, Feb. 4 (HealthDay News) -- Drug-coated stents are better ... research finds. , "There are two messages I would take ... professor of cardiology at Wake Forest University and lead author ... Journal of the American College of Cardiology. "The ...
... has,agreed to settle for $2.5 million, plus interest, ... program, the Justice Department,announced today. The settlement is ... Medical Center is currently in bankruptcy., The ... to Medicare patients in order to obtain enhanced,reimbursement ...
... ALTO, Calif., Feb. 4 Formerly conjoined twins,Yurelia ... at Stanford and are now home in Costa ... Children,s last Wednesday (30) and went,to Southern California ... sponsor the girls, trip. Today (4), they flew ...
... Those with poor balance, dementia, vision loss most in peril, ... -- Certain people are at high risk for accidental falls ... number of fall-related injuries and deaths in the United States, ... States, accidental falls result in 1.8 million emergency room visits ...
Cached Medicine News:Health News:Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases 2Health News:Drug-Coated Stents Better Than Bare-Metal Ones in Complex Cases 3Health News:Buyer of Bayonne Hospital to Pay U.S. $2.5 Million to Resolve Allegations of Medicare Fraud 2Health News:Formerly Conjoined Twins Leave Packard Children's Hospital; Heading Home to Costa Rica 2Health News:New Guideline Urges Screening for Fall Risk 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: